~~<i id='CF66ECCD2D'><strike id='CF66ECCD2D'><tt id='CF66ECCD2D'><pre id='CF66ECCD2D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：hotspot 2025-09-30 12:18:38 - browse：3

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

focus

hotspot

Wikipedia

entertainment

Wikipedia

entertainment

AtUkraine'sDniproStateMedicalUniversity(picturedherein2013),therehasn’tbeenanewcancerdrugtrialstarte

WSS

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Weight loss drugs aren’t covered by Obamacare. That may change

Ukraine seeks to reclaim its role as a hub for clinical trials

Military medical care influenced by rank and race, new study finds

focus

explore

focus

Walensky prepares to leave CDC — and Congress — behind

Opioid cravings were reduced by anti

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

In Memoriam: Notable people who died in 2023

Military medical care influenced by rank and race, new study finds

Medicare details structure of new drug price negotiation program

Surprise medical billing ban raises prices elsewhere

Virginia high school admissions case could be legal follow

With measles on the rise, a personal story of a devastating disease

hotspot

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

In 'major milestone,' FDA approves first cell therapy for solid tumors

A new drug could help frostbite victims avoid its ravages

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Measles policy set amid Florida outbreak alarms vaccine proponents

Surprise medical billing ban raises prices elsewhere

Wikipedia

entertainment

Wikipedia

entertainment